HARMONY - A Trial to Evaluate the Safety and Efficacy of Amitiza (Lubiprostone) in Children with Constipation

Submitted by centretek on Sat, 10/15/2022 - 10:29
Source URL
https://www.inova.org/clinical-trials/harmony-trial-evaluate-safety-and-efficacy-amitiza-lubiprostone-children
Description
General Information Age Group Pediatrics/Children Status Active Protocol Number N/A Background Information The goal of this study is to evaluate the safety and efficacy of Amitiza (lubiprostone) in children with constipation. Even though traditional treatment of functional constipation in children is available and safe, for many patients it does not provide a satisfying improvement, prompting interest in other therapeutic strategies.  Since lubiprostone has been shown to increase the frequency of spontaneous bowel movements (SBMs) in both adults and children, further evaluation in well controlled studies in children is needed to demonstrate use in a paediatric population. Study requires use of an electronic diary nightly, 6 visits and 5 blood draws. Eligibility Information Children 6 to 18 years old with constipation Contact Information Contact Name Suchitra Hourigan, MD Contact Phone 703-876-2788 Contact Email Send Email
Clinical Trials Sub categories
Colorectal
Crawled Content Type
Clinical Trials
Summary
The goal of this study is to evaluate the safety and efficacy of Amitiza (lubiprostone) in children with constipation. Even though traditional treatment of functional constipation in children is available and safe, for many patients it does not provide a satisfying improvement, prompting interest in other therapeutic strategies. Since lubiprostone has been shown to increase the frequency of spontaneous bowel movements (SBMs) in both adults and children, further evaluation in well controlled studies in children is needed to demonstrate use in a paediatric population. Study requires use of an electronic diary nightly, 6 visits and 5 blood draws.
Age Group
Pediatrics/Children
is_synonym
Off
Also a children's page
Off